Survivin regulates the p53 tumor suppressor gene family

被引:71
|
作者
Wang, ZX
Fukuda, S
Pelus, LM
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[3] Walther Canc Inst, Indianapolis, IN 46202 USA
关键词
survivin; apoptosis; p53; p63; p73;
D O I
10.1038/sj.onc.1207992
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin regulates cell division and inhibits apoptosis by blocking caspase activation. The tumor suppressor p53 inhibits cell cycle progression and induces apoptosis. Since Survivin overexpression and loss of wild-type p53 expression/function occur in most cancers, we investigated whether Survivin regulates p53. Stable overexpression of Survivin protects BaF3 cells from Adriamycin-induced apoptosis, while dominant-negative (T34A) and antisense (AS) Survivin accelerate apoptosis. In BaF3 cells and transiently transfected MCF7 breast cancer cells, elevation of total and phospho-Ser(15)-p53 in response to Adriamycin is blocked by Survivin and enhanced by Survivin disruption. Furthermore, in Adriamycin-treated MCF7 cells, ectopic Survivin decreased p53 mRNA and increased mRNA and protein of the p53 homologues DeltaNp63 and TAp73 and mRNA for DeltaNp73, suggesting that Survivin may differentially regulate p53 family transcription. Concomitant with decreasing p53 mRNA, Survivin decreased Mdm2 mRNA. Survivin disruption by T34A or AS Survivin resulted in reduced Mdm2 protein. The caspase inhibitor, Z-VAD-FMK, blocked the decrease in Mdm2 as well as the increase in p53 resulting from Survivin disruption, indicating that Survivin regulates Mdm2 at the post-translational level. Proteosome inhibition confirmed that reduced p53 protein observed in cells overexpressing Survivin is due to enhanced p53 degradation resulting from Survivin-mediated inhibition of Mdm2 cleavage by caspases. In summary, our results identify regulatory interactions between Survivin and p53 at the mRNA and protein levels, and suggest that the p53 homologues DeltaNp63, TAp73 and DeltaNp73 may also be regulated by Survivin.
引用
收藏
页码:8146 / 8153
页数:8
相关论文
共 50 条
  • [21] Analysis of the p53 tumor suppressor gene by pyrosequencing
    Ahmadian, A
    Lundeberg, J
    Nyrén, P
    Uhlén, M
    Ronaghi, M
    BIOTECHNIQUES, 2000, 28 (01) : 140 - +
  • [22] p53 tumor suppressor gene in acoustic neuromas
    Monoh, K
    Ishikawa, K
    Yasui, N
    Mineura, K
    Andoh, H
    Togawa, K
    ACTA OTO-LARYNGOLOGICA, 1998, : 11 - 15
  • [23] Overexpression of p53 tumor suppressor gene in pterygia
    O Weinstein
    G Rosenthal
    H Zirkin
    T Monos
    T Lifshitz
    S Argov
    Eye, 2002, 16 : 619 - 621
  • [24] The functions of the p53 tumor suppressor gene product
    Murphy, ME
    Levine, AJ
    FASEB JOURNAL, 1997, 11 (09): : A1448 - A1448
  • [25] p53 tumor suppressor gene therapy for cancer
    Roth, JA
    Swisher, SG
    Meyn, RE
    ONCOLOGY-NEW YORK, 1999, 13 (10): : 148 - 154
  • [26] p53 tumor suppressor gene therapy for cancer
    Nielsen, LL
    Maneval, DC
    CANCER GENE THERAPY, 1998, 5 (01) : 52 - 63
  • [27] Early diversification and complex evolutionary history of the p53 tumor suppressor gene family
    Aurora M. Nedelcu
    Christopher Tan
    Development Genes and Evolution, 2007, 217 : 801 - 806
  • [28] Early diversification and complex evolutionary history of the p53 tumor suppressor gene family
    Nedelcu, Aurora M.
    Tan, Christopher
    DEVELOPMENT GENES AND EVOLUTION, 2007, 217 (11-12) : 801 - 806
  • [29] The Tumor Suppressor, p53 Regulates the γA-Crystallin Gene During Mouse Lens Development
    Hu, X. -H.
    Nie, Q.
    Yi, M.
    Li, T. -T.
    Wang, Z. -F.
    Huang, Z. -X.
    Gong, X. -D.
    Zhou, L.
    Ji, W. -K.
    Hu, W. -F.
    Liu, J. -F.
    Wang, L.
    Woodward, Z.
    Zhu, J.
    Liu, W. -B.
    Nguyen, Q. D.
    Li, D. W. -C.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (09) : 1197 - 1204
  • [30] THE P53 TUMOR-SUPPRESSOR GENE AND TUMOR PROGNOSIS - IS THERE A RELATIONSHIP
    DOWELL, SP
    HALL, PA
    JOURNAL OF PATHOLOGY, 1995, 177 (03): : 221 - 224